Live
- Kiran Abbavaram's Hard Work Pays Off: Bunny Vasu Lauds Ka Team at Success Meet
- PM Modi’s welfare schemes transform rural lives in Bokaro, residents share gratitude
- We will ensure Bangladeshi infiltrators are removed from Jharkhand: BJP's Gourav Vallabh
- Hezbollah fires five rockets at central, northern Israel: sources
- HM Amit Shah, Rajnath Singh to address several rallies in Jharkhand tomorrow
- Will not waste single day in getting back what we lost, Omar Abdullah tells Assembly
- PM Modi visits Advani's residence to wish him on birthday, shares special moment
- Sun-Dried Cotton to Be Taken to CCI Purchase Centers, Avoid Middlemen - Collector
- Survey Process Requires Public Cooperation - Collector Badavath Santosh
- Distribution of Maize Seeds to Farmers at Agricultural Research Center
US Congressmen seek briefing on drugs from India
A bipartisan group of powerful US lawmakers on Wednesday sought a congressional briefing on contaminated drugs from India and China used in the treatment of high blood pressure
Washington:A bipartisan group of powerful US lawmakers on Wednesday sought a congressional briefing on contaminated drugs from India and China used in the treatment of high blood pressure.
Since July last year, at least 15 recalls have been issued for a class of drugs known as angiotensin II receptor blockers (ARB), which are generally used to treat high blood pressure.
The recalls appear to be connected to at least two foreign drug manufacturing facilities – Zhejiang Huahai Pharmaceutical in China and Hetero Labs in India.
Both facilities have a history of troubling FDA inspection reports prior to the detection of trace amounts of carcinogens, the bipartisan energy and commerce Congressmen said in a letter to the US' Food and Drug Administration (FDA) Commissioner Scott Gottlieb.
Expressing concern, the lawmakers requested a briefing on drugs manufactured overseas that may have been contaminated with trace amounts of known carcinogens.
